Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrating pharmacogenomic testing into paired germline and somatic genomic testing in patients with cancer.

Pharmacogenomics - 1 Aug 2023

Seligson Nathan D, Kolesar Jill M, Alam Benish, Baker Laura, Lamba Jatinder K, Fridley Brooke L, Salahudeen Ameen A, Hertz Daniel L, Hicks J Kevin

Abstract excerpt

Precision medicine has revolutionized clinical care for patients with cancer through the development of targeted therapy, identification of inherited cancer predisposition syndromes and the use of pharmacogenetics to optimize pharmacotherapy for anticancer drugs and supportive care medications. While germline (patient) and somatic (tumor) genomic testing have evolved separately, recent interest in paired...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics

Share to Germ-Line Mutation

Share to Neoplasms

Share to Pharmacogenetics

Share to Pharmacogenomic Testing

Share to Precision Medicine

Source

Identifiers

PMID: 37702060
DOI: 10.2217/pgs-2023-0125

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrating pharmacogenomic testing into paired germline and somatic genomic testing in patients with cancer.PMID 37702060Read ↗

Integrating Somatic and Germline Pharmacogenomics for Therapeutic Decisions in Precision Oncology.Semantic proximity Read ↗

Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance.Semantic proximity Read ↗

Aligning Germline Cancer Predisposition With Tumor-Based Next-Generation Sequencing for Modern Oncology Diagnosis, Interception, and Therapeutic DevelopmentSemantic proximity Read ↗

Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories.Semantic proximity Read ↗

Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectivesSemantic proximity Read ↗

The Future of Parallel Tumor and Germline Genetic Testing: Is There a Role for All Patients With Cancer?Semantic proximity Read ↗

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.Semantic proximity Read ↗

Germline sequencing for presumed germline pathogenic variants via tumor-only comprehensive genomic profilingSemantic proximity Read ↗

Clinical Integration of Germline Findings from a Tumor Testing Precision Medicine ProgramSemantic proximity Read ↗

Innovation in cancer pharmacotherapy through integrative consideration of germline and tumor genomesSemantic proximity Read ↗

Modern developments in germline pharmacogenomics for oncology prescribingSemantic proximity Read ↗

Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.